The data indicated that 30.5% (25/82) of tumours showed reduced or absent expression of HBP1 while β-catenin nuclear accumulation was found in 40.2% (33/82) of NSCLC, respectively (Table S2). This evidence concerns the gene HBP1 and non-small cell lung carcinoma.